NCT02940002 - BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

January 27, 2017

Study Completion Date

March 17, 2017

Conditions

Psoriasis

Interventions

DRUG

BAY1003803

Simultaneous application of 10μl on psoriasis plaque and on healthy skin for 4 weeks and evaluation of pharmacodynamic effect

DRUG

Clobetasol propionate

Simultaneous application of 10μl on psoriasis plaque and on healthy skin for 4 weeks and evaluation of pharmacodynamic effect

DRUG

Betamethasone/calcipotriene

Simultaneous application of 10μl on healthy skin for 4 weeks and evaluation of pharmacodynamic effect

Trial Locations (3)

Schwerin

Hamburg

Bochum